Freightos director granted 97,562 additional RSUs
Freightos Ltd director Udo Lange reported an amended equity award that increases a prior restricted share unit grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Freightos Ltd director Udo Lange reported an amended equity award that increases a prior restricted share unit grant. He received an additional 97,562 ordinary shares represented by RSUs, bringing the total grant to 121,952 ordinary shares represented by 121,952 RSUs.
The 121,952 RSUs will vest and settle in equal annual installments of 30,488 ordinary shares on each of the first four anniversaries of the original July 28, 2025 grant date, so all shares are due by July 28, 2029. Separate RSU-based ordinary share holdings began vesting on October 1, 2025 and vest quarterly through October 1, 2026, subject to board meeting attendance.
Lange also directly holds stock options over 100,000 ordinary shares at an exercise price of $5.00, 100,000 at $10.00, and 100,000 at $15.00 per share, all expiring on July 28, 2032, providing additional long-term equity exposure.
Insider Trade Summary
Grant/Award: 97,562 shares
Grant/Award
6 txns
Insider
Lange Udo
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 97,562 | $0.00 | $0.00 |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 185,468 shares (Direct);
Stock Option (right to buy) — 300,000 contracts (Direct)
Footnotes (5)
- F1. The transaction reported in this row consists of an amendment to an existing grant of restricted shares units ("RSUs") to the Reporting Person, which amendment was approved by the Issuer's board of directors on April 28, 2026. Under the amended terms, the Reporting Person received a finite number of additional ordinary shares represented by RSUs currently, with an annual vesting schedule, instead of being entitled to receive indeterminable numbers of additional ordinary shares at later dates based on the market price of the Issuer's ordinary shares at such later dates.
- F2. Under the prior grant terms, the Reporting Person had been granted 24,390 ordinary shares represented by 24,390 RSUs that began vesting on July 28, 2025 and that were to vest (and settle for 24,390 underlying ordinary shares) on the one-year anniversary of the vesting commencement date (July 28, 2026) (in addition to indeterminable numbers of additional ordinary shares to be granted later). Under the revised grant terms, in lieu of those future grants, the Reporting Person received a finite, additional 97,562 ordinary shares currently, represented by 97,562 RSUs, such that the total grant has been set at 121,952 ordinary shares represented by 121,952 RSUs.
- F3. The subject 121,952 ordinary shares consist of shares underlying 121,952 RSUs that will vest and settle in equal annual installments, for 30,488 ordinary shares each, on the first four anniversaries of the original July 28, 2025 grant date, such that all 121,952 ordinary shares will be received by the Reporting Person by July 28, 2029.
- F4. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F5. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on October 1, 2025 and that vest (and settle for underlying ordinary shares) equally on a quarterly basis (25% of the RSUs per quarter) such that all such RSUs will be vested by the one-year anniversary of the grant date (October 1, 2026). Vesting is subject to the Reporting Person's fulfilling minimum attendance requirements at meetings of the Issuer's board of directors.
Key Figures
Additional RSUs granted: 97,562 ordinary shares
Total RSU grant: 121,952 ordinary shares
Annual vesting installment: 30,488 ordinary shares
+3 more
6 metrics
Additional RSUs granted
97,562 ordinary shares
Finite additional ordinary shares represented by RSUs granted under amended terms
Total RSU grant
121,952 ordinary shares
Total ordinary shares represented by RSUs after amendment
Annual vesting installment
30,488 ordinary shares
Equal annual installments on first four anniversaries of July 28, 2025
Option at $5.00
100,000 underlying shares
Stock option exercise price $5.0000, expiration July 28, 2032
Option at $10.00
100,000 underlying shares
Stock option exercise price $10.0000, expiration July 28, 2032
Option at $15.00
100,000 underlying shares
Stock option exercise price $15.0000, expiration July 28, 2032
Key Terms
restricted shares units ("RSUs"), vesting, stock option (right to buy), exercise price, +1 more
5 terms
vesting financial
"The subject 121,952 ordinary shares consist of shares underlying 121,952 RSUs that will vest and settle in equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
stock option (right to buy) financial
"Stock Option (right to buy) ... underlying security title Ordinary Shares"
exercise price financial
"Stock Option (right to buy) ... conversion_or_exercise_price "5.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date "2032-07-28T00:00:00.000Z" for the stock options reported"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Freightos (CRGO) director Udo Lange acquire in this Form 4 filing?
Udo Lange received an additional 97,562 ordinary shares represented by restricted share units, increasing a prior grant to a total of 121,952 ordinary shares represented by 121,952 RSUs approved by Freightos’ board on April 28, 2026.
How will Udo Lange’s 121,952 Freightos (CRGO) RSUs vest over time?
The 121,952 ordinary shares underlying RSUs will vest and settle in four equal annual installments of 30,488 shares on each anniversary of the July 28, 2025 grant date, so all shares are scheduled to be received by July 28, 2029.
What stock options in Freightos (CRGO) does Udo Lange hold according to this filing?
Lange holds stock options giving rights to buy 100,000 ordinary shares at $5.00, 100,000 at $10.00, and 100,000 at $15.00 per share, all expiring on July 28, 2032, each referencing underlying ordinary shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
